Dockovalent specifications


Unique identifier OMICS_13716
Name Dockovalent
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained Yes



  • person_outline Jack Taunton <>

Publication for Dockovalent

Dockovalent institution(s)
Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA; Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, CA, USA; Faculty of Pharmacy & Ontario Institute for Cancer Research, University of Toronto, Toronto, Canada; Clermont Université, UMR 1071 Inserm/Université d’Auvergne, Clermont-Ferrand, France; INRA, USC 2018, Clermont-Ferrand, France; Service de Bactériologie, Centre Hospitalier Universitaire, Clermont-Ferrand, France
Dockovalent funding source(s)
This work was supported by US NIH grant GM59957, by NIH GM71896, by the Ministère de la Recherche et de la Technologie, the Institut national de la santé et de la recherche médicale (UMR Inserm U1071), the Institut National de la Recherche Agronomique (USC-2018), and the Centre Hospitalier Régional Universitaire de Clermont-Ferrand, France. It was also partly supported by an EMBO long term fellowship (ALTF 1121-2011) and the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation, by a fellowship from California TRDRP (#19FT-0091), and by Howard Hughes Medical Institute Predoctoral Fellowhip.

Dockovalent reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Dockovalent